CONTACT US
Latest News from the RAS Initiative Symposium
For decades, one of the biggest challenges facing the cancer research community has been finding a way to therapeutically target […]
READ MORE
Oncologist Is Humbled, Inspired by His Patients
Growing up, Marcus Noel, MD, always enjoyed science – especially biology. He also loved sports and dreamt of playing professional […]
READ MORE
PanCAN Initiatives Highlighted at Gastrointestinal Cancers Conference
The 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium took place Jan. 18-20 in San Francisco, bringing […]
READ MORE
PanCAN’s Annual Scientific Summit Convenes Our Community for Progress
Grantees, advisors and others came together for science, mentorship and networking.
In Memoriam: Honoring the Legacy of a Researcher, Advisor, Advocate and Friend
PanCAN mourns the loss of Gloria Petersen, PhD.
Positive Clinical Trial Results Highlighted at Gastrointestinal Cancers Conference
Results from the NAPOLI 3 clinical trial were presented at the ASCO GI Symposium.
5 Things to Know about BRCA Mutations and Pancreatic Cancer
Find out how BRCA mutations can impact pancreatic cancer risk and treatment options.
Back in Person, PanCAN Scientific Summit Offers Data-sharing, Discussion and Progress
The PanCAN Scientific Summit allowed for data-sharing, discussion and collaboration.
PanCAN Announces Its Largest-ever Research and Research Grants Investment
PanCAN is investing nearly $25 million in conducting and funding research in 2022.
Recap of the Largest-Ever American Society of Clinical Oncology Meeting
Clinical trial results and PanCAN’s initiatives were highlighted at major meeting.
In the News: Pancreatic Cancer Patient Responds to Novel Immunotherapy Approach
A patient who responded well to a novel immunotherapy approach is in the news.
PanCAN’s Research Grants Program: Translating Lab Progress to Future Patient Benefit
Learn about two PanCAN-funded projects with promising results.
Inaugural PanCAN Therapeutic Accelerator Award Goes to Verastem Oncology
PanCAN will provide $3.8 million to Verastem Oncology for innovative clinical trial.
Listen to Patients, Improve Education to Combat Cancer Cachexia, Workshop Advises
A recent workshop yielded new insights into how to improve treatment for cachexia.
Let’s Talk About: Inequities in Access to Genetic Testing
Dr. Rodriguez discusses inequities in access to genetic testing and education.
1st Experimental Drug Tested in PanCAN Precision Promise Is Discontinued
Patients – and their safety – are at the center of every decision.
Progress Highlighted at Gastrointestinal Cancers Symposium
Get the latest news from PanCAN’s Know Your Tumor and other clinical trial progress.
The Changing Clinical Trials Landscape
Clinical trials are testing new treatment approaches and becoming more innovative.
2021 Year in Review: Progress in Research
Thanks to you, we’re making progress toward early detection and better treatments.
COVID-19 Vaccine Frequently Asked Questions
Learn about COVID-19 vaccines and booster shots from PanCAN’s chief medical officer.
PanCAN Scientific Summit Recap
PanCAN grantees, advisers, industry members and guests gathered to discuss research.
Virtual Conference Highlights Real, Exciting Progress
Conference featured exciting new results, robust discussion and a look to the future.
Hispanic Heritage Month: Exploring Clinical Trial Diversity and Disparities in Pancreatic Cancer Patient Outcomes
We spoke with experts about diversity and equity in clinical trials and patient care.
What Pancreatic Cancer Researchers Can Learn from the Patient’s Voice
Data published from PanCAN’s Patient Registry show power of patient-reported outcomes
New Study Describes Treatment Approach for a Subset of Pancreatic Cancer Patients
PanCAN and partners published a study about RAF alterations in patients’ tumors.
13 Research Grant Recipients Announced
Meet this year’s research grant recipients and learn about their projects.
New Advisory Board Chair Has Been Part of PanCAN Since the Beginning
Dr. Tempero will help guide scientific and clinical initiatives and priorities.
5 Things to Know About Targeting Mutant KRAS in Pancreatic Cancer
Editor’s note: Originally published in February 2021, we’ve updated this article to include the exciting news that the first drug […]
READ MORE
The Latest in Early Detection for Pancreatic Cancer: Webinar Highlights
A panel of experts discusses screening tests to find pancreatic cancer earlier.
New Study Provides Recommendations to Manage Pancreatic Cancer Pain
The Precision Promise Supportive Care Committee published a paper on pain management.
Why PanCAN’s Chief Science Officer Launched the Early Detection Initiative
Chief Science Officer Lynn Matrisian shares her priorities, proudest accomplishments.
6 Things You Need to Know about Diabetes and Pancreatic Cancer
Diabetes can be both a risk factor and an early symptom of pancreatic cancer.
Introducing PanCAN’s Early Detection Initiative
Earlier detection leads to more treatment options and improved survival.
New Paper Highlights Urgent Need for Pancreatic Cancer Progress
PanCAN and partners published new projections about cancer cases and deaths today.
Grantees’ Intercontinental Journeys to Pancreatic Cancer Research
Editor’s note: In honor of International Women’s Day, we are celebrating several PanCAN research grant recipients whose experiences in different […]
READ MORE
Black Americans at Increased Risk for Pancreatic Cancer
Awareness of both the risk factors and symptoms of the disease is important.
The Latest News from the Gastrointestinal Cancers Symposium
The 2021 Gastrointestinal (GI) Cancers Symposium recently brought together oncologists, researchers, patients and patient advocates, including the Pancreatic Cancer Action […]
READ MORE
Life Is Back to Normal for 5-Year Stage IV Survivor
“Life is basically back to normal.” These are the words of five-year stage IV pancreatic cancer survivor, Lynne Holcomb, of […]
READ MORE
Cases Increase; PanCAN Is Here to Help
Every day in 2021, 166 Americans will learn that they have pancreatic cancer. That’s 60,430 people who are predicted to […]
READ MORE
2020 Year in Review: Advocacy Accomplishments
Editor’s note: In today’s edition of our Year in Review series, we’re looking back at the wins you made possible […]
READ MORE
2020 Year in Review: Research Progress
Editor’s note: Today’s article looks back at scientific and clinical advances made in 2020 and kicks off our Year in […]
READ MORE
Breaking News: Federal Research Program for Pancreatic Cancer Increases to $15 Million
Thousands of advocates delivered a strong message to Capitol Hill: Make pancreatic cancer a national priority. And Congress responded. Congress […]
READ MORE
5 Health & Safety Tips for Winter
Tips to keep you and your loved ones safe with vaccines, masks, tests and planning.
Robert Tells Fellow Survivors: ‘You Are Not Alone’
Robert Duran was told he had pancreatic cancer – not just once, or twice. Three times. PanCAN’s Patient Services has supported him every step of the way […]
Key Takeaways from Clinical Research Webinar
Get a recap of our World Pancreatic Cancer Day webinar featuring an expert panel discussing the latest in clinical research […]
Why Nancy Supports Ingunn’s Pancreatic Cancer Research
After losing her mom and uncle to pancreatic cancer, Nancy made an impact by donating to PanCAN to fund Ingunn’s early-career research […]
PanCAN Mourns the Death of Alex Trebek
We join the world in mourning the death of Alex Trebek, who had stage IV pancreatic cancer. The longtime host […]
READ MORE
Do You Know Your Risk?
If you have a first-degree relative (parent, child or sibling) who was diagnosed with pancreatic cancer, you may have an […]
READ MORE
Data from PanCAN’s Patient Registry Presented at Quality Care Symposium
The Pancreatic Cancer Action Network’s (PanCAN) Patient Registry is a global online database created to look for patterns in treatments, […]
READ MORE
Meet a Research Grantee: Daria Esterházy, PhD
Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE
Meet a Research Grantee: Krushna Patra, PhD
Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE
Meet a Research Grantee: Susan Bates, MD
Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE
PanCAN’s Annual Scientific Summit Goes Virtual
The Pancreatic Cancer Action Network’s (PanCAN) Annual Scientific Summit may have looked different this year, but some things stayed the […]
READ MORE
PanCAN Is Accepting 2021 Research Grant Applications
Applications are now being accepted for Pancreatic Cancer Action Network (PanCAN) Career Development Awards. PanCAN has awarded Career Development Awards […]
READ MORE
Meet a Research Grantee: Xiaoyang Qi, PhD
Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE
Frequently Asked Questions About Coronavirus and Pancreatic Cancer: Part 2
Editor’s note: In March, we published an article about coronavirus disease (COVID-19) and how it impacts pancreatic cancer patients. As […]
READ MORE
Meet a Research Grantee: Jill Smith, MD
Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE
New Guidelines Emphasize Biomarker & Genetic Testing
In its latest guidelines for the treatment of patients with metastatic pancreatic cancer, the American Society of Clinical Oncology (ASCO) […]
READ MORE
Meet a Research Grantee: Alexander Muir, PhD
Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE
Exciting News: $15 Million Proposed for Pancreatic Cancer Research Program at the Department of Defense
Today, thanks to Pancreatic Cancer Action Network’s (PanCAN) tireless advocates, the U.S. House of Representatives passed a Department of Defense […]
READ MORE
Things to Know About Immunotherapy Clinical Trials
Editor’s note: “Jeopardy!” host Alex Trebek and former Sen. Harry Reid have publicly mentioned being treated with an experimental immunotherapy […]
READ MORE
Meet a Research Grantee: Gillian Gresham, PhD
Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE
Meet a Research Grantee: Mustafa Raoof, MD, FACS
Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE
Meet a Research Grantee: Fengzhi Li, PhD
Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE
PanCAN Awards 10 New Pancreatic Cancer Research Grants
Thanks to the generosity of our donors and supporters, we are pleased to announce that the Pancreatic Cancer Action Network […]
READ MORE
PanCAN Japan President Receives Prestigious Public Service Award
The American Association of Cancer Research (AACR) has awarded Yoshiyuki Majima, PhD, MPH, its prestigious Distinguished Public Service Award. Majima […]
READ MORE
Why It’s Important to Advocate for Yourself During Coronavirus Pandemic
You are your own best advocate. If you’ve been diagnosed with a disease like pancreatic cancer, it’s important to get […]
READ MORE
PanCAN Presents at International Oncology Conference
The theme for the 2020 American Society of Clinical Oncology’s (ASCO) Annual Meeting was “Unite & Conquer: Accelerating Progress Together.” […]
READ MORE
Friday Fix: Pancreatic Cancer and Smoking
People who smoke cigarettes are two times as likely to develop pancreatic cancer.
Virtual Advocacy Week Starts Monday!
Monday, June 15Join us for our live, free Advocacy Week Kick-off Event featuring special guests! Hear from advocates and special […]
READ MORE
Doctor Shares How to Be a Patient Champion
Christos Fountzilas, MD, is proud to be a member of the Pancreatic Cancer Action Network’s (PanCAN) Patient Champions program. “PanCAN […]
READ MORE
Research Grantees Stay Connected During Coronavirus Pandemic
Editor’s note: May is National Cancer Research Month, which provides an opportunity to highlight the incredible scientific and clinical research […]
READ MORE
Grantees Explore New Treatment Combination
All the way across the country from one another, two pancreatic cancer researchers made similar discoveries in their labs. Rushika […]
READ MORE
5 Ways for Pancreatic Cancer Patients to Prepare for Telemedicine Visits
Because of the coronavirus disease (COVID-19) pandemic, many Americans and people around the world have been instructed to practice social […]
READ MORE
Friday Fix: Anemia and Pancreatic Cancer
Editor’s note: This week’s Friday Fix focuses on anemia, a condition when your red blood cell count is too low. […]
READ MORE
Grantee Helps Fight Coronavirus Disease (COVID-19)
Pancreatic Cancer Action Network (PanCAN) research grantee Kenneth Olive, PhD, is dedicated to keeping his lab as connected as possible […]
READ MORE
Friday Fix: How Can Foods Boost Your Immune System?
Editor’s note: Because of the current coronavirus disease (COVID-19) pandemic, we’re focusing this week’s Friday Fix on foods and behaviors […]
READ MORE
Staying Connected with PanCAN During Social Distancing
Editor’s note: Please continue to follow the U.S. Centers for Disease Control (CDC) for up-to-date information and guidelines about coronavirus […]
READ MORE
Frequently Asked Questions About Coronavirus Disease (COVID-19) and Pancreatic Cancer
Editor’s note: Please continue to follow the U.S. Centers for Disease Control (CDC) for up to date information and guidelines […]
READ MORE
PanCAN’s Response to Coronavirus Disease (COVID-19)
Editor’s note, March 16, 2020: The coronavirus disease (COVID-19) pandemic is changing daily. Please watch the U.S. Centers for Disease […]
READ MORE
PanCAN’s Know Your Tumor Can Help Pancreatic Cancer Patients Live Longer
The Pancreatic Cancer Action Network’s (PanCAN) Know Your Tumor® precision medicine service can help pancreatic cancer patients live longer. Know […]
READ MORE
‘Clinical Cancer Advances’ Report Highlights Pancreatic Cancer Progress
The American Society of Clinical Oncology (ASCO) released its “Clinical Cancer Advances 2020” report earlier this week – aptly timed […]
READ MORE
Accelerating Personalized Care for Pancreatic Cancer Patients
“Accelerating Personalized Care” was the theme for the 2020 Gastrointestinal (GI) Cancers Symposium, which took place Jan. 23-25 in San […]
READ MORE
Shedding Light on Clinical Trials: Clinical Trial Participation
Editor’s note: During January, Pancreatic Cancer Clinical Trials Awareness Month, we are featuring a “Shedding Light on Clinical Trials” series […]
READ MORE
Shedding Light on Clinical Trials: Clinical Trial Landscape
Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Throughout the month, we will feature a “Shedding Light on […]
READ MORE
Pancreatic Cancer Survival Rate Reaches 10%
For the first time ever, the five-year survival rate for pancreatic cancer has reached double digits. American Cancer Society’s Cancer […]
READ MORE
2019 Year in Review: Progress in Research
Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE
New Pancreatic Cancer Tumor Categories May Inform Treatment Decisions
New research suggests that pancreatic tumors can be classified into two broad categories – and this information can help guide […]
READ MORE
Grantee Finds New Pancreatic Cancer Drug Target
The goal of cancer treatment is to identify – and attack – vulnerabilities that make cancer cells different from healthy […]
READ MORE
U.S. Senator Holds Pancreatic Cancer Congressional Field Hearing
In response to the disease’s impact on his constituents in Alabama, Sen. Doug Jones (D-AL) presided over a hearing entitled, […]
READ MORE
In Memoriam: David Boothman, PhD
We are extremely sad to share that Pancreatic Cancer Action Network (PanCAN) research grant recipient David Boothman, PhD, died on […]
READ MORE
Two Pancreatic Cancer Clinical Trials Do Not Improve Survival
The results from two phase III clinical trials for pancreatic cancer patients were recently announced. Both Lilly’s SEQUOIA and Halozyme’s […]
READ MORE
Matched Therapy Increases Pancreatic Cancer Survival
People with pancreatic cancer and a specific type of change – or mutation – in their DNA live longer when […]
READ MORE
Reaching New Heights at 2019 Scientific Summit
Editor’s note: The Pancreatic Cancer Action Network’s (PanCAN) Annual Scientific Summit took place earlier this month in Coral Gables, Fla. […]
READ MORE
Young Father Vows to Fight the Disease for His Sons
Editor’s note: We are deeply saddened to share that Adam Deal died of pancreatic cancer in December 2020. His advocacy […]
READ MORE
34-year-old Survivor Responds Well to Targeted Therapy
Editor’s note: We are deeply saddened to share that Adam Deal died of pancreatic cancer in December 2020. His advocacy […]
READ MORE
Experts Discuss Adaptive Platform Clinical Trials
Clinical trials are necessary to determine whether a drug or treatment combination is safe, effective and an improvement over the […]
READ MORE
Pancreatic Cancer Immunotherapy Clues Revealed
When immunology expert Ingunn Stromnes, PhD, assistant professor of microbiology and immunology at the University of Minnesota, unexpectedly discovered a […]
READ MORE
Task Force Updates Pancreatic Cancer Screening Recommendations
The U.S. Preventive Services Task Force (USPSTF) continues to recommend against population-wide screening for pancreatic cancer, as announced today on […]
READ MORE
Meet a Research Grantee: Yuan Chen, PhD
Editor’s note: We recently announced the recipients of our 2019 research grants, awarded through a competitive, peer-review process. Now we’d […]
READ MORE
Comparing Pancreatic Tumor Tissue Types for Molecular Profiling
When the Pancreatic Cancer Action Network (PanCAN) launched its Know Your Tumor® precision medicine service, molecular profiling was offered for […]
READ MORE
Using Physics to Improve Pancreatic Cancer Early Detection
How does someone trained in spin physics – the study of the “magnetic moment” of elementary particles – apply that […]
READ MORE
What Is Cancer Immunotherapy?
It’s Cancer Immunotherapy Month. Here, we discuss immunotherapy and pancreatic cancer.
5 Things to Know About Precision Medicine
Every pancreatic tumor – and every pancreatic cancer patient – is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends […]
READ MORE
Best Practices for Pancreatic Enzymes Paper Published
The symptoms patients may experience leading up to their pancreatic cancer diagnosis – including weight loss, abdominal pain and changes […]
READ MORE
Positive Clinical Trial Results Presented at Major Oncology Conference
This year’s American Society of Clinical Oncology (ASCO) Annual Meeting has brought 40,000 oncologists and other cancer experts from around […]
READ MORE
‘Bench to Bedside’ Project Shows Promise in Pancreatic Cancer Patients
A new treatment combination – combining chemotherapy and radiation therapy with a common blood pressure drug – has shown promise […]
READ MORE
PNET Survivor Receives ‘Gift’ Through Molecular Profiling
The morning of Feb. 5, 2016, started like many for Gail. She got up early and headed to the gym […]
READ MORE
Moments Matter: Andy Hospodor, PhD
Editor’s note: We are very sad to share that Dr. Andy Hospodor also died of pancreatic cancer on June 19, […]
READ MORE
Our Founder Reflects on Women’s Health Month
Simply put, the Pancreatic Cancer Action Network (PanCAN) would not exist without Pamela Acosta Marquardt. “It all started with […]
READ MORE
A Look into the Research Lab
Editor’s note: May is National Cancer Research Month, and we recently had the opportunity to speak with two leading pancreatic […]
READ MORE
Team Alex Supports Alex Trebek at PurpleStride L.A.
As Pancreatic Cancer Action Network (PanCAN) supporters in Southern California gear up for PurpleStride Los Angeles on May 4, a […]
READ MORE
NCI Increases Pancreatic Cancer Research Funding
Nearly $178 million was invested in pancreatic cancer research by the National Cancer Institute (NCI) in 2017 – a 17 […]
READ MORE
New Criteria for Pancreatic Cancer Surgery
Editor’s note: A study published last week has gotten some media attention, including this NBC News article that includes insights […]
READ MORE
PanCAN Leader ‘Blown Away’ by Cancer Conference
“I’ve been attending the American Association for Cancer Research (AACR) annual meetings for several years, and this year’s conference was […]
READ MORE
Grantee Discovers New Therapeutic Target in Pancreatic Cancer Cells
A study published in Nature today describes how mutant KRAS impacts pancreatic cancer cells’ ability to gather nutrients – and […]
READ MORE
Lynch Syndrome and Pancreatic Cancer Risk
About 10 percent of pancreatic cancer cases are thought to be hereditary – caused by an inherited genetic alteration that […]
READ MORE
Large-scale Molecular Profiling Reveals Clues About Pancreatic Tumors and Cysts
The largest-ever molecular analysis of pancreatic cancer tissue samples – from more than 3,500 patients – revealed some new clues […]
READ MORE
Young Mom with Pancreatic Cancer Advocates for Herself
When Allison Perlis of Potomac, Md., first began experiencing symptoms of pancreatic cancer in early 2017, she dismissed them as […]
READ MORE
How Pancreatic Cancer Cells Target the Liver
New donor-funded research published today in the journal Nature describes signals that prepare the liver in advance for pancreatic cancer […]
READ MORE
Two Studies Point to New Combination Treatment for Pancreatic Cancer
Editor’s note: Hear directly from pancreatic cancer researcher Kirsten Bryant, PhD, and Julie Fleshman, president and CEO of the Pancreatic […]
READ MORE
What a Researcher Learned Developing a New Drug for Pancreatic Cancer
Editor’s note: In this Washington Post article, Nathaniel Brooks Horwitz wrote about his experience launching biopharmaceutical company Nivien Therapeutics in […]
READ MORE
Pancreatic Cancer Treatment in the News
“There is no way to sugarcoat the fact that pancreatic cancer is very difficult to treat,” begins an article recently […]
READ MORE
African-American 2019 Cancer Stats Released
In addition to its annual Cancer Facts & Figures report, the American Cancer Society (ACS) releases cancer data specific to […]
READ MORE
It Starts with Someone: Barbara Kenner, PhD
Editor’s note: Our “It Starts with Someone” series chronicles all kinds of Pancreatic Cancer Action Network (PanCAN) supporters – volunteers, […]
READ MORE
How to Spot Fake Science News
Do you ever see scientific or medical headlines that sound too good to be true? Ask these questions to help […]
READ MORE
Report Highlights Clinical Cancer Advances
The American Society of Clinical Oncology (ASCO) has released their Clinical Cancer Advances 2019 report. The report outlines progress over […]
READ MORE
3 Things to Know About Pancreatic Cancer Blood Tests
Pancreatic cancer is notoriously difficult to find in its earlier, and more treatable stages. For this reason, research teams across […]
READ MORE
3 Posters, 1 Major Conference
A large group of Pancreatic Cancer Action Network (PanCAN) leadership and Scientific and Medical Affairs staff are attending the 2019 […]
READ MORE
Grantee Tries to Stop Cells Turning into Cancer
Even before certain cells of the pancreas become cancer, changes occur in their ability to break down nutrients, according to […]
READ MORE
Increase in Pancreatic Cancer Diagnoses Expected in 2019
More than 56,700 Americans will be diagnosed with pancreatic cancer in 2019, today’s American Cancer Society Cancer Facts & Figures […]
READ MORE
2018 Year in Review: Progress in Research, Part 2
Editor’s note: Today’s edition of the 2018 Year in Review series continues the topic of research. Yesterday’s article covered treatment […]
READ MORE
2018 Year in Review: Progress in Research, Part 1
Editor’s note: Welcome to the first article in our 2018 Year in Review series! Over the next couple weeks, we’ll […]
READ MORE
Brother’s Tumor Caught Early, Thanks to Genetic Testing
Editor’s note: In light of Pancreatic Cancer Awareness Month and our focus on the importance of biomarker and genetic testing, […]
READ MORE
5 Things to Know About Hereditary Pancreatic Cancer
Editor’s note: Last year, we shared information about hereditary pancreatic cancer during November, Pancreatic Cancer Awareness Month. Since then, there […]
READ MORE
Guidelines Updated to Encourage Genetic Testing
The American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) provide the healthcare community with current […]
READ MORE
New Cancer Drug Approved Based on Molecular Profiling
The U.S. Food and Drug Administration (FDA) approved Vitrakvi® (larotrectinib) today for the treatment of any locally advanced or metastatic solid tumor, […]
READ MORE
PanCAN’s President and CEO Featured at People v. Cancer Event
The Atlantic’s People v. Cancer event took place Nov. 14, 2018, in New York City. The event featured a stellar […]
READ MORE
Public Misguided about Alternative Medicine, Says Chief Medical Officer
When asked whether alternative medicines alone could cure cancer, nearly 40 percent of Americans recently surveyed answered yes. “This is […]
READ MORE
Understanding Pancreatic Cancer Risk Factors
In November, Pancreatic Cancer Awareness Month, the focus is on raising awareness about risk factors and symptoms of pancreatic cancer. […]
READ MORE
5 Things to Know about Pancreatic Cancer Surgery
For eligible patients, surgery is the best option for long term survival of pancreatic cancer. Data show high volume surgeons […]
READ MORE
‘Contacting PanCAN Was the Best Thing I Did’
Editor’s note: Sadly, Gail Bamer died in July 2019. We are grateful to her for allowing her story to be […]
READ MORE
Ask PanCAN Patient Services: Molecular Profiling
The Pancreatic Cancer Action Network (PanCAN) offers an Ask PanCAN Patient Services series to provide helpful tips and information about […]
READ MORE
It Starts with Someone: Willy Hoos
Editor’s note: Our “It Starts with Someone” series chronicles all kinds of Pancreatic Cancer Action Network (PanCAN) supporters – volunteers, […]
READ MORE
1,000th Patient Receives Know Your Tumor® Report
The Pancreatic Cancer Action Network (PanCAN) has now delivered personalized molecular profiling reports to 1,000 pancreatic cancer patients through its […]
READ MORE
Nobel Prize-Winning Chemist Dies of Pancreatic Cancer
Thomas A. Steitz, PhD, died of pancreatic cancer on Oct. 9, 2018, at the age of 78, according to news […]
READ MORE
Cancer Immunotherapy Pioneers Win Nobel Prize in Physiology or Medicine
The 2018 Nobel Prize in Physiology or Medicine has been awarded to James (Jim) Allison, PhD, and Tasuku Honjo, MD, […]
READ MORE
Wall Street Journal Reports How Genetics Affect Risk and Treatments
“I was 7 years old when my dad’s mom, Gertrud, was diagnosed with breast cancer,” began Pamela Munster, MD, a […]
READ MORE
Teen Hopes Artificial Intelligence Will Improve Patient Outcomes
Editor’s note, Oct. 17, 2018: We are delighted to report that Rishab Jain won the Discovery Education 3M Young Scientist […]
READ MORE
Persistence, Precision Medicine Pay off for Pancreatic Cancer Patient
When doctors told David Watson of Santa Monica, Calif., that he had type 2 diabetes in November 2016, he couldn’t […]
READ MORE
New Global Cancer Statistics Released
The International Agency for Research on Cancer (IARC) released new global cancer statistics on Sept. 12. Of the 18 million […]
READ MORE
2018 Progress Report: ‘Incredibly Exciting Time for Cancer Research’
Every year, the American Association for Cancer Research (AACR), the oldest and largest organization dedicated to advancing cancer research, publishes […]
READ MORE
Biomarker Test May Improve Pancreatic Cancer Early Detection
In a study recently published in the prestigious Journal of Clinical Oncology, researchers investigated the accuracy of a biomarker panel […]
READ MORE
What Are Pancreatic Cancer Biomarkers?
A biomarker is a substance found in the body that can be measured. The amount of a biomarker may vary […]
READ MORE
4 Common Hospice Care, Palliative Care Myths
Editor’s note: We join the nation in mourning the death of Sen. John McCain to glioblastoma, an extremely aggressive form […]
READ MORE
Pancreatic Cancer Researchers, Clinicians ‘Unlock Superpowers’ at Annual Scientific Summit
The fitting theme for this year’s Pancreatic Cancer Action Network (PanCAN) Annual Scientific Summit, occurring Aug. 23-26, 2018, in San […]
READ MORE
Young Bride Chooses Molecular Profiling and Clinical Trial
Before Allison Lippman of Dallas met her now-husband, she was not convinced she wanted to date anyone. “I was turning […]
READ MORE
What You Need to Know About Genetic and Molecular Testing
Editor’s note, March 2, 2020: Results published in Lancet Oncology from the Pancreatic Cancer Action Network’s (PanCAN) Know Your Tumor® […]
READ MORE
It Starts with Someone: Drs. Michael Curran and Randy Pausch
Editor’s note: On July 25, 2008, 10 years ago today, professor Randy Pausch, PhD, of “The Last Lecture” fame, died […]
READ MORE
Meet Our 2018 Research Grantees: Translational Awards
This year, the Pancreatic Cancer Action Network (PanCAN) awarded eight prestigious research grants to scientists and clinicians in the United […]
READ MORE
New Research Suggests Age May Benefit Response to Immunotherapy
Cancer immunotherapy involves efforts to harness the patient’s own immune system to recognize and attack tumor cells. To date, the […]
READ MORE
Meet Our 2018 Research Grantees: Early Career Awards
The Pancreatic Cancer Action Network (PanCAN) recently announced this year’s recipients of prestigious research grants. Funding decisions were made by […]
READ MORE
PanCAN Publishes Hopeful Precision Medicine Results
Published today in the esteemed Clinical Cancer Research, a journal of the American Association for Cancer Research, the Pancreatic Cancer […]
READ MORE
New Study Encourages Genetic Testing for All Pancreatic Cancer Patients, Regardless of Family History
A pancreatic cancer diagnosis can lead to a lot of questions, including how to choose a healthcare team, deciding on […]
READ MORE
Prestigious Scientific Panel Discusses Key Topics at Pancreatic Cancer Advocacy Day
Today at National Pancreatic Cancer Advocacy Day, a prestigious panel of scientific and clinical leaders discussed key topics surrounding the […]
READ MORE
Institution’s Molecular Profiling Results Affect Clinical Decisions
Every pancreatic tumor is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends molecular profiling of your tumor to help […]
READ MORE
What to Know About Groundbreaking New FOLFIRINOX Clinical Trial Results
Editor’s note: You may have heard breakthrough news that came out of the American Society of Clinical Oncology (ASCO) Annual […]
READ MORE
Breakthrough: Studies Show Benefit of Treatments Before and After Surgery
On day four of the American Society of Clinical Oncology (ASCO) Annual Meeting, results of two critically important phase III […]
READ MORE
6 Things to Know about Cancer Blood Tests, or Liquid Biopsies, for Early Detection
Editor’s note: There is news coming out of the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June […]
READ MORE
Things to Know about Muscle-Wasting Syndrome, Cachexia
Many pancreatic cancer patients experience weight loss, which can be caused or made worse by treatment as well as the […]
READ MORE
Clinical Guidelines for Metastatic Disease Updated
The American Society of Clinical Oncology (ASCO) has updated their treatment guidelines for patients with metastatic pancreatic cancer, or disease […]
READ MORE
Annual Cancer Report Highlights Urgency for Progress
Today, the Annual Report to the Nation on the Status of Cancer was released. The report is prepared by the […]
READ MORE
Researchers Set Sights on New Early Detection Blood Test
A team of researchers from the University of California, San Diego (UCSD), recently published a study evaluating a new strategy […]
READ MORE
Is There a Screening Strategy for Pancreatic Cancer?
Editor’s note: You may have heard earlier this week on our website and from other media sources that former Senate […]
READ MORE
Tips for Coping with Nausea and Vomiting
You may have spoken with friends or family members on chemotherapy, or seen TV or movie depictions of someone undergoing […]
READ MORE
A Grantee’s Long Road ‘Home’ to Research
If you had asked Jason Doles, PhD, five years ago where he anticipated he’d be today, he would not have […]
READ MORE
New Treatment Guidelines to Improve Patient Options
Editor’s note: Below we describe recent updates to the National Comprehensive Cancer Network’s (NCCN) guidelines for the treatment and management […]
READ MORE
Celebrate National DNA Day with Five Key Facts
Did you know that DNA gets its own day? It’s today! National DNA Day has been celebrated since 2003, when […]
READ MORE
More than 20,000 Cancer Researchers Converge at International Meeting
The theme for this year’s American Association for Cancer Research (AACR) Annual Meeting, which took place earlier this week in […]
READ MORE
Blood Pressure Medication and Pancreatic Cancer Risk
Announced at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, a new study suggests that a popular […]
READ MORE
National Doctors’ Day: Honoring Roles and Importance of Specialists
Editor’s note: Today is National Doctors’ Day, and we are celebrating the critical roles of various specialists in the diagnosis […]
READ MORE
National Doctors’ Day: Honoring Roles of Surgeons and Radiation Oncologists
Editor’s note: This is the second of three articles leading up to National Doctors’ Day on March 30. We are […]
READ MORE
National Doctors’ Day: Honoring Roles of Gastroenterologists and Pathologists
Editor’s note: Leading up to National Doctors’ Day on March 30, we’re highlighting the critical roles of various medical disciplines […]
READ MORE
Grantee’s Study Suggests Bacteria Can Influence Tumor Growth and Immune Response
Scientists have known for quite some time that pancreatic tumors are surrounded by an especially dense and complex “stroma,” a […]
READ MORE
It Starts with Someone: Drs. Howard Crawford and Lynn Matrisian
Editor’s note: Our “It Starts with Someone” series chronicles all kinds of Pancreatic Cancer Action Network (PanCAN) supporters – volunteers, […]
READ MORE
When Characterizing Cysts, You Should Look at the Entire Pancreas, Experts Say
When a cyst is detected in someone’s pancreas, the first priority is characterizing the type of cyst – and determining […]
READ MORE
5 Reasons Why Clinical Trials Are Safe
Patient safety is a top priority in all clinical trials.
NPR Focuses on One of the Biggest Challenges in Pancreatic Cancer: KRAS
About 95 percent of pancreatic cancer cases – and around 30 percent of all human cancers – have a mutation […]
READ MORE
Precision Medicine Highlighted in the News
“All Cancer Patients Should Have Access To Genomic Testing” is the title of a compelling article featured in Forbes earlier […]
READ MORE
Precision Promise Spotlighted at International Conference
The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2018) took place earlier this week in Berlin. The […]
READ MORE
Study Shows Quality of Life Impacts Survival
A pancreatic cancer diagnosis – and the side effects sometimes caused by treatments – can take an enormous toll on […]
READ MORE
Love at First Lab Meeting
Both Wantong Yao, MD, PhD, and Haoqiang Ying, MD, PhD, underwent medical training in China. They both became deeply interested […]
READ MORE
Lutathera® Drug Approved for Pancreatic Neuroendocrine Tumors
Today, the U.S. Food & Drug Administration (FDA) approved Lutathera® (lutetium-177 (177Lu)-Dotatate) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), […]
READ MORE
6 Things to Know about the CancerSEEK Test and Early Detection
Editor’s note: You may have seen stories in the news and here on our website about a new blood test […]
READ MORE
Can a Blood Test Lead to Early Detection?
Yesterday, a collaborative team of scientists, primarily from Johns Hopkins University, published a paper in the well regarded journal Science, […]
READ MORE
Grantee’s Work Explains Stress in Disease Progression
Two-time Pancreatic Cancer Action Network (PanCAN) research grant recipient, Timothy Wang, MD, set out to answer an unusual question: How […]
READ MORE
New Report Highlights Pancreatic Cancer Prevalence
Today, the American Cancer Society (ACS) released its 2018 Cancer Facts & Figures, an annual report that analyzes cancer statistics […]
READ MORE
2017 Year in Review: Progress in Research, Part 2
Editor’s note: Welcome to the second part of our 2017 research highlights recap (we’re pretty excited that it’s taking two […]
READ MORE
Keytruda Drug Is Science Breakthrough of the Year Runner-up
At the end of every year, Science magazine announces a Breakthrough of the Year – a discovery that revolutionized the […]
READ MORE
2017 Year in Review: Progress in Research, Part 1
Editor’s note: This article is the first in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE
The NCI Funds Early Detection
The National Cancer Institute (NCI) recently funded four new teams of researchers through its Pancreatic Cancer Detection Consortium (PCDC). According […]
READ MORE
Discovery of Rare Mutation Gives Survivor Options, Hope
Akshay Mehta, MD, was in the middle of performing an orthopedic surgery when his first pancreatic cancer symptom arose. “I […]
READ MORE
Survey Highlights the Importance of Seeing Specialists
Published in the Journal of Gastrointestinal Cancer, a recent survey of 150 oncologists showed a lack of compliance with evidence-based […]
READ MORE
Is Pancreatic Cancer Hereditary?
About 5 to 10 percent of pancreatic cancer cases are considered to be hereditary or familial. “Hereditary disease generally means […]
READ MORE
Post-Traumatic Stress Disorder (PTSD) and Cancer
Editor’s Note: Originally published in November 2017, this blog post was updated in May 2023. It is not unusual for […]
READ MORE
In Memoriam: Kenneth Scott, PhD
Pancreatic cancer researcher Kenneth Scott, PhD, associate professor of molecular and human genetics at Baylor College of Medicine, passed away […]
READ MORE
Research Team’s Work Provides Clues that Explain Long-term Survival
A multi-institutional research team, including Vinod Balachandran, MD, and Steven Leach, MD, set out to ask an important question: “What […]
READ MORE
In Quest to Understand His Father’s Illness, a Young Doctor Discovers His Own
In August 2017, oncologist Mark Lewis, MD, underwent a Whipple surgical procedure for his pancreatic neuroendocrine tumor (PNET). But his […]
READ MORE
Tumor’s Genetic Changes Can Impact Patient Outcomes
Among the many genetic mutations and molecular alterations that can be found in pancreatic tumors, there are four that are […]
READ MORE
Can Aspirin Reduce Pancreatic Cancer Risk?
Results from a study presented at the 25th United European Gastroenterology (UEG) Week meeting in Barcelona suggest that long-term, low-dose aspirin use […]
READ MORE
Type 3c Diabetes Is Often Misdiagnosed, Potentially Delaying Pancreatic Cancer Diagnoses
While most people are familiar with types 1 and 2 diabetes, there is a third, less common type, known as […]
READ MORE
Patient Registry Findings Presented at Major Meeting
Good nutritional care improves outcomes and is critical for a patient’s quality of life. The Pancreatic Cancer Action Network (PanCAN) […]
READ MORE
Register for ‘Cancer Research & Oncology 2017’ Virtual Conference
The Cancer Research & Oncology 2017 virtual conference will take place Oct. 11 to 12, beginning at 6 a.m. PDT. […]
READ MORE
Cancer Drugs in the News
An article published yesterday in Newsweek describes a European analysis that found cancer drugs are being approved without adequate evidence […]
READ MORE
Grantee Describes New Test to Characterize Pancreatic Cysts
In a forward-looking study of patients diagnosed with various types of cysts of the pancreas, researchers at the University of […]
READ MORE
Study Identifies Surprising Culprit for Chemotherapy Resistance: Bacteria
Sometimes the most unexpected and unusual observations in the laboratory can lead to important results. Such was the case when […]
READ MORE
Progress Report: ‘Research Continues to Be Our Best Defense Against Cancer’
The American Association for Cancer Research (AACR) released its annual Cancer Progress Report earlier this week. “Research continues to be […]
READ MORE
The Power of Positive Thinking
When someone is diagnosed with cancer, battle metaphors often prevail – He is such a fighter! She will win this […]
READ MORE
Forbes Article Discusses Potential of PARP Inhibitors to Treat Certain Pancreatic Cancer Patients
The so-called breast cancer genes BRCA1 and BRCA2 were originally found to increase a woman’s risk of breast cancer when […]
READ MORE
PanCAN Is Here to Help During a Natural Disaster
Whether it’s hurricanes, storms, wildfires or earthquakes, we’re all vulnerable to the risk – and reality – of natural disasters. […]
READ MORE
Nanotechnology Approach to Imaging for Early Detection
Back when he was a postdoctoral researcher, grantee Kazuki Sugahara, MD, PhD, found that a peptide, or small piece of […]
READ MORE
5 Questions & Answers About the ‘BiliScreen App’ to Detect Pancreatic Cancer Through Selfies
You may have seen the news about a new app, called BiliScreen, being developed at the University of Washington that […]
READ MORE
Annual Scientific Meeting Gathers Key Pancreatic Cancer Research Stakeholders
“This is a meeting like no other – and this is an organization like no other!” Thus began the Pancreatic […]
READ MORE
New Findings Explain How Immune Cells Support Pancreatic Tumors
A Pancreatic Cancer Action Network Career Development Award in 2014 allowed David DeNardo, PhD, to ask and answer important questions […]
READ MORE
Nationwide Effort Uncovers Genetic Clues in Pancreatic Cancer Cells
The cleverly named The Cancer Genome Atlas project – abbreviated TCGA, in homage to the four base pairs that make […]
READ MORE
Grantee’s Study Offers Explanation, Potential Treatment Strategy for Obesity-Associated Pancreatic Cancer
When Nada Kalaany, PhD, set out to establish an independent lab at Boston Children’s Hospital, she was determined to answer […]
READ MORE
Tiny Balls of Pancreatic Cancer Cells Teach Researchers About Metastasis
One of the biggest challenges faced by scientists trying to solve lingering mysteries about the biology of pancreatic cancer is […]
READ MORE
Grantees Collaborate to Understand Treatment Resistance
The chemotherapy gemcitabine is widely used to treat pancreatic cancer patients. However, many patients develop resistance to the drug, leading […]
READ MORE
PanCAN Bolsters Distinguished Scientific and Medical Advisory Board
We are delighted to announce the addition of five national leaders in the pancreatic cancer space to our prestigious Scientific […]
READ MORE
New Study Identifies Test to Diagnose Benign Pancreatic Cysts
Imagine that your doctor just told you that you have a cyst on your pancreas. She informs you that the […]
READ MORE
Cancer Progress Spotlighted in the News
Earlier this month, nearly 40,000 clinical oncologists, cancer researchers and other healthcare and industry professionals convened in Chicago for the […]
READ MORE
5 Things to Know About New Drug Keytruda
Editor’s note: Keytruda was the first cancer drug approved to treat any solid tumor – anywhere in the body – […]
READ MORE
The Power of Patient-reported Outcomes
A study presented at an esteemed plenary session of the American Society of Clinical Oncology (ASCO) Annual Meeting and published […]
READ MORE
Results of Large-scale Molecular Profiling Effort Are Published, Shared
The American Association for Cancer Research (AACR) is spearheading a large-scale molecular profiling effort called Project Genomics Evidence Neoplasia Information […]
READ MORE
The Road to Effective Immunotherapy for Pancreatic Cancer Patients
Last week, we shared the exciting news that an immunotherapy agent, Keytruda, was the first drug approved by the FDA […]
READ MORE
Unprecedented Drug Approval Can Benefit Pancreatic Cancer Patients
For the first time, the U.S. Food and Drug Administration (FDA) has approved a cancer drug based only on molecular […]
READ MORE
It Starts with Someone: Florencia McAllister
Editor’s note: This story was originally published in 2016, but we are sharing it again this month in celebration and […]
READ MORE
Deviant Immune Cells Incite Pancreatic Cancer
An all-star collaboration between three Pancreatic Cancer Action Network research grant recipients, representing three different institutions, has shown that immune […]
READ MORE
Critical Clues Toward Targeting KRAS Mutations
Two new research studies offer encouraging steps toward developing effective therapies to target the notoriously challenging RAS mutations. About 95 […]
READ MORE
Rare but Targetable Genetic Change Discovered in Pancreatic Cancer Patients
The Pancreatic Cancer Action Network’s state-of-the-art Know Your Tumor® precision medicine service offers molecular profiling to eligible patients. Molecular profiling […]
READ MORE
Large-scale Study Shows Benefit of Molecular Profiling
The rationale behind the Pancreatic Cancer Action Network’s revolutionary Know Your Tumor® precision medicine service is to use molecular profiling […]
READ MORE
New Study Reinforces Recommendations that Pancreatic Cancer Patients Travel to Academic Centers for Surgery
A new study published in the Journal of the American College of Surgeons finds that pancreatic cancer patients who travel […]
READ MORE
“I’m Drawn to Tough Challenges!” A Conversation with Dr. Andrew Hendifar
Research funding is critical to improving pancreatic cancer patient outcomes. But unfortunately, there simply isn’t enough of it. A study […]
READ MORE
Implantable Device Could Improve Immunotherapy Delivery, Effectiveness
A collaborative effort between researchers at the Fred Hutchinson Cancer Research Center, the University of Washington and Massachusetts Institute of […]
READ MORE
Grantee’s Discovery Validated by New Study Highlighting Strategy to Improve Drug Delivery
A novel peptide (small piece of protein) developed by a Pancreatic Cancer Action Network grantee was shown to benefit a […]
READ MORE
Pancreatic Cancer Highlighted at Record-breaking Scientific Conference
Last week, nearly 22,000 cancer researchers from around the world gathered in Washington, D.C., for the largest-ever American Association for […]
READ MORE
A New Strategy to Allow Immune Attack of Pancreatic Tumors
The more researchers analyze the interaction between pancreatic cancer cells and the patient’s immune system, the more complex the relationship […]
READ MORE
Celebrating New Research Grantees at International Meeting
Grantees and scientific leadership celebrating at awards dinner On the evening of Tuesday, April 4, the Pancreatic Cancer Action Network (PanCAN), […]
READ MORE
Smoking Increases Risk of Developing, Dying from Pancreatic Cancer
As a risk factor, smoking is thought to contribute to about 20 percent of pancreatic cancer cases. Now, new research […]
READ MORE
Leadership Discusses Pancreatic Cancer Research Funding, New Report
The Pancreatic Cancer Action Network’s Scientific & Medical Affairs team acknowledged for key contributions to a study analyzing the pancreatic […]
READ MORE
Julie Fleshman Discusses Clinical Trial Innovation and Precision Medicine Amongst Leaders of Renowned Biomedical Research Funders
On March 23 and 24, Julie Fleshman, JD, MBA, the Pancreatic Cancer Action Network’s president and CEO, was invited to […]
READ MORE
Cancer Care Report: Patient-centric, Evidence-based Medicine Critical for Future Success
Last year, a staggering 1.7 million Americans were diagnosed with cancer – and more than 15.5 million people were living […]
READ MORE
Our Grantees Featured at Major International Cancer Research Conference
What would you do with $1 million to improve outcomes for pancreatic cancer patients? A diverse group of seven research […]
READ MORE
Critical Benchmarks Defined for Pancreatic Cancer Research Progress
It’s not every day that more than 450 pancreatic cancer researchers get together to talk about key topics in the […]
READ MORE
Former Vice President Joe Biden Headlines “Connect to End Cancer” Session at South by Southwest Conference
The fight against cancer is deeply personal for former Vice President Joe Biden, who lost his son, Beau, to brain […]
READ MORE
Meet Dr. Vince Picozzi, Chair of the Precision Promise Clinical Trial Consortium
Meet Vincent Picozzi, Jr., MD, director of the pancreaticobiliary program at the Floyd & Delores Jones Cancer Institute at Virginia […]
READ MORE
Prestigious promotion for member of our research community
We are delighted to report that our grantee, Brian Wolpin, MD, MPH, has been appointed Robert T. and Judith B. […]
READ MORE
Standing room-only crowd attends congressional briefing, raising awareness for our nation’s deadliest cancers
The deadliest cancers in the United States are defined by the Recalcitrant Cancer Research Act, legislation the Pancreatic Cancer Action […]
READ MORE
How Diabetes Can Be an Early Sign of Pancreatic Cancer
There is a complex relationship between diabetes and pancreatic cancer – diabetes can be considered both a symptom and a […]
READ MORE
Running Away from Home: Grantee Explores What Makes Pancreatic Cancer Cells Spread
Changes that cause a normal cell to become cancerous are often genetic in nature – mutations or altered expression of […]
READ MORE
Can Aspirin Reduce Your Risk of Pancreatic Cancer?
Aspirin and its potential to reduce the risk of pancreatic cancer has been a topic making headlines the past few […]
READ MORE
Grantees Use Two-part Attack to Outsmart Pancreatic Cancer Cells
Researchers and clinicians have spent decades trying to devise ways to stop the growth and aggressive properties of pancreatic cancer […]
READ MORE
Oral Bacteria Linked to Pancreatic Cancer Risk in Grantee Study
In April 2016, Jiyoung Ahn, PhD, recipient of the 2012 The Daniel and Janet Mordecai – Career Development Award, presented […]
READ MORE
Blue Ribbon Panel Recommendations Hold Potential to Improve Outcomes for Recalcitrant Cancers, Like Pancreatic Cancer
On September 7, 2016, the Cancer Moonshot Blue Ribbon Panel released a report describing 10 recommendations to make a decade’s […]
READ MORE
Annual Scientific Meeting Brings Together and Strengthens our Community for Progress
Our Annual Scientific Meeting took place August 18 – 21 in beautiful San Diego, bringing together research grant recipients, current […]
READ MORE
Research Team’s $1 Million Grant Funds Efforts toward Earlier Detection of Pancreatic Cancer
One of the reasons that pancreatic cancer is particularly challenging to clinicians is that the majority of cases are diagnosed […]
READ MORE
Grantee’s Preclinical Immunotherapy Data Shows Promise
Pancreatic cancer recently moved from the fourth to the third leading cause of cancer-related death in the United States, and […]
READ MORE
New Study of Pancreatic Cancer Clinical Trials Reveals Opportunities for the Future
A rigorous analysis of 25 years’ worth of pancreatic cancer clinical trial data was published on June 6, 2016, in […]
READ MORE
American Association for Cancer Research Annual Meeting Convenes our Community for Progress
From April 16 to April 20, nearly 20,000 cancer researchers from around the world gathered in New Orleans for the […]
READ MORE
Grant Recipient and His Collaborative Team Identify Cells that Can Give Rise to Pancreatic Cancer
In an insightful study published in the major journal Cell Stem Cell, Timothy Wang, MD, together with his colleagues and […]
READ MORE
Grantee’s Findings About Pancreatic Cancer Cell Death Could Impact Future Treatments
The discovery of a new mode of pancreatic cancer cell death may play an important role in cancer cells’ survival.
Grantee’s Early-Phase Immunotherapy Clinical Trial Shows Encouraging Results
Preliminary results from an early-phase immunotherapy clinical trial suggest that an innovative treatment could be effective for patients with locally-advanced or borderline-resectable pancreatic cancer.
